Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies.

Cervantes-Madrid D, Wettergren Y, Falk P, Lundholm K, Asting AG.

BMC Cancer. 2017 Mar 27;17(1):219. doi: 10.1186/s12885-017-3206-8.

2.

Clinical and Biological Features of Interval Colorectal Cancer.

Lee YM, Huh KC.

Clin Endosc. 2017 May;50(3):254-260. doi: 10.5946/ce.2016.115. Epub 2017 Mar 21. Review.

3.

Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks.

Fortunato A, Boddy A, Mallo D, Aktipis A, Maley CC, Pepper JW.

Cold Spring Harb Perspect Med. 2017 Feb 1;7(2). pii: a029652. doi: 10.1101/cshperspect.a029652. Review.

4.

Tumor suppressor protein DAB2IP participates in chromosomal stability maintenance through activating spindle assembly checkpoint and stabilizing kinetochore-microtubule attachments.

Yu L, Shang ZF, Abdisalaam S, Lee KJ, Gupta A, Hsieh JT, Asaithamby A, Chen BP, Saha D.

Nucleic Acids Res. 2016 Oct 14;44(18):8842-8854. Epub 2016 Aug 27.

5.

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.

Sveen A, Løes IM, Alagaratnam S, Nilsen G, Høland M, Lingjærde OC, Sorbye H, Berg KC, Horn A, Angelsen JH, Knappskog S, Lønning PE, Lothe RA.

PLoS Genet. 2016 Jul 29;12(7):e1006225. doi: 10.1371/journal.pgen.1006225. eCollection 2016 Jul.

6.

Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.

Mima K, Nowak JA, Qian ZR, Cao Y, Song M, Masugi Y, Shi Y, da Silva A, Gu M, Li W, Hamada T, Zhang X, Wu K, Meyerhardt JA, Baba H, Giovannucci EL, Chan AT, Fuchs CS, Ogino S, Nishihara R.

Oncotarget. 2016 Aug 23;7(34):55098-55109. doi: 10.18632/oncotarget.10398.

7.

Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways.

Frohwitter G, Buerger H, VAN Diest PJ, Korsching E, Kleinheinz J, Fillies T.

Oncol Lett. 2016 Jul;12(1):107-113. Epub 2016 May 16.

8.

Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression.

Chuang TP, Wang JY, Jao SW, Wu CC, Chen JH, Hsiao KH, Lin CY, Chen SH, Su SY, Chen YJ, Chen YT, Wu DC, Li LH.

Oncotarget. 2016 Jul 19;7(29):45803-45818. doi: 10.18632/oncotarget.9960.

9.

Emerging molecular classifications and therapeutic implications for gastric cancer.

Chen T, Xu XY, Zhou PH.

Chin J Cancer. 2016 May 27;35:49. doi: 10.1186/s40880-016-0111-5. Review.

10.

The Dark Side of Cell Fusion.

Bastida-Ruiz D, Van Hoesen K, Cohen M.

Int J Mol Sci. 2016 Apr 28;17(5). pii: E638. doi: 10.3390/ijms17050638. Review.

11.

Modeling the Etiology of p53-mutated Cancer Cells.

Perez RE, Shen H, Duan L, Kim RH, Kim T, Park NH, Maki CG.

J Biol Chem. 2016 May 6;291(19):10131-47. doi: 10.1074/jbc.M116.724781. Epub 2016 Mar 28.

12.

Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.

Lee S, Kopp F, Chang TC, Sataluri A, Chen B, Sivakumar S, Yu H, Xie Y, Mendell JT.

Cell. 2016 Jan 14;164(1-2):69-80. doi: 10.1016/j.cell.2015.12.017. Epub 2015 Dec 24.

13.

Prognostic significance of FAM83D gene expression across human cancer types.

Walian PJ, Hang B, Mao JH.

Oncotarget. 2016 Jan 19;7(3):3332-40. doi: 10.18632/oncotarget.6620.

14.

Delayed Numerical Chromosome Aberrations in Human Fibroblasts by Low Dose of Radiation.

Cho YH, Kim SY, Woo HD, Kim YJ, Ha SW, Chung HW.

Int J Environ Res Public Health. 2015 Dec 1;12(12):15162-72. doi: 10.3390/ijerph121214979.

15.

PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanisms.

Li XL, Zhou J, Chan ZL, Chooi JY, Chen ZR, Chng WJ.

Oncotarget. 2015 Nov 3;6(34):36689-99. doi: 10.18632/oncotarget.5385.

16.

Mouse models of intestinal cancer.

Jackstadt R, Sansom OJ.

J Pathol. 2016 Jan;238(2):141-51. doi: 10.1002/path.4645. Epub 2015 Oct 29. Review.

17.

Reduced rate of copy number aberrations in mucinous colorectal carcinoma.

Hugen N, Simmer F, Mekenkamp LJ, Koopman M, van den Broek E, de Wilt JH, Punt CJ, Ylstra B, Meijer GA, Nagtegaal ID.

Oncotarget. 2015 Sep 22;6(28):25715-25. doi: 10.18632/oncotarget.4706.

18.

Epigenetic regulation of the intestinal epithelium.

Elliott EN, Kaestner KH.

Cell Mol Life Sci. 2015 Nov;72(21):4139-56. doi: 10.1007/s00018-015-1997-9. Epub 2015 Jul 29. Review.

19.

Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

Reid BJ, Paulson TG, Li X.

Gastroenterology. 2015 Oct;149(5):1142-1152.e3. doi: 10.1053/j.gastro.2015.07.010. Epub 2015 Jul 21. Review.

20.

Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.

de Groen FL, Timmer LM, Menezes RX, Diosdado B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

PLoS One. 2015 Jul 6;10(7):e0132495. doi: 10.1371/journal.pone.0132495. eCollection 2015.

Supplemental Content

Support Center